A new approach to oxidative stress and inflammatory signaling during labour in healthy mothers and neonates

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Díaz Castro, Javier ^a   Florido, Jesus ^a,b   Kajarabille, Naroa ^a   Prados, Sonia ^a,b   De Paco, Catalina ^a,b   Ocon, Olga ^a,b   Pulido Moran, Mario ^a   Ochoa, Julio J ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; HEALTH CARE; MEDICINE;

ANTIOXIDANT ENZYME; INFLAMMATORY CYTOKINES; INFLAMMATORY PROCESS; INFLAMMATORY SIGNALING; NEW APPROACHES; OVER-EXPRESSION; OXIDATIVE DAMAGE; UMBILICAL CORDS;

OXIDATIVE STRESS;

INTERLEUKIN 6; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 2; CATALASE; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR;

ADULT; ANTIOXIDANT ASSAY; ARTICLE; CHILDBIRTH; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; HUMAN; INFLAMMATION; LABOR; MALE; NEWBORN; NORMAL HUMAN; OXIDATIVE STRESS; PROSTAGLANDIN BLOOD LEVEL; PROTEIN BLOOD LEVEL; SIGNAL TRANSDUCTION; UMBILICAL ARTERY; UMBILICAL VEIN; BLOOD; FETUS BLOOD; GESTATIONAL AGE; METABOLISM; MOTHER; PREGNANCY;

ADULT; CATALASE; DINOPROSTONE; FEMALE; FETAL BLOOD; GESTATIONAL AGE; GLUTATHIONE PEROXIDASE; HUMANS; INFANT, NEWBORN; INTERLEUKIN-6; LABOR, OBSTETRIC; MOTHERS; OXIDATIVE STRESS; PREGNANCY; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84923884922     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/178536     Document Type: Article

References (48)

1. O. D. Saugstad, "Oxygen toxicity in the neonatal period," Acta Paediatrica Scandinavica, vol. 79, no. 10, pp. 881-892, 1990.
2. T. Metsvaht, P. Ilves, T. Talvik, K. Zilmer, M. Zilmer, and R. Talvik, "Possible oxidative stress in healthy term newborns," Acta Paediatrica, vol. 88, no. 11, pp. 1299-1300, 1999.
3. J. J. Ochoa, M. C. Ramirez-Tortosa, J. L. Quiles et al., "Oxidative stress in erythrocytes from premature and full-term infants during their first 72 h of life," Free Radical Research, vol. 37, no. 3, pp. 317-322, 2003.
4. J. J. Ochoa, F. Contreras-Chova, S. Muñoz et al., "Fluidity and oxidative stress in erythrocytes from very low birth weight infants during their first 7 days of life," Free Radical Research, vol. 41, no. 9, pp. 1035-1040, 2007.
5. S. Stipek, A. Mechurova, J. Crkovska, T. Zima, and J. Platenik, "Lipid peroxidation and superoxide dismutase activity in umbilical and maternal blood," Biochemistry and Molecular Biology International, vol. 35, no. 4, pp. 705-711, 1995.
6. M. W. Tomlinson, T. J. Caruthers, J. E. Whitty, and B. Gonik, "Does delivery improve maternal condition in the respiratorycompromised gravida?" Obstetrics and Gynecology, vol. 91, no. 1, pp. 108-111, 1998.
7. A. Fernández-Sánchez, E. Madrigal-Santillán, M. Bautista et al., "Inflammation, oxidative stress, and obesity," International Journal of Molecular Sciences, vol. 12, no. 5, pp. 3117-3132, 2011.
8. H. S. Brar, L. D. Platt, G. R. DeVore, J. Horenstein, and A. L. Medearis, "Qualitative assessment of maternal uterine and fetal umbilical artery blood flow and resistance in laboring patients byDoppler velocimetry,"TheAmerican Journal ofObstetrics and Gynecology, vol. 158, no. 4, pp. 952-956, 1988.
9. C. Li and R. M. Jackson, "Reactive species mechanisms of cellular hypoxia-reoxygenation injury," The American Journal of Physiology-Cell Physiology, vol. 282, no. 2, pp. C227-C241, 2002.
10. R.W. Kelly, "Inflammatory mediators and parturition," Reviews of Reproduction, vol. 1, no. 2, pp. 89-96, 1996.
11. S. Argüelles, M. J. Machado, A. Ayala, A. Machado, and B. Hervías, "Correlation between circulating biomarkers of oxidative stress of maternal and umbilical cord blood at birth," Free Radical Research, vol. 40, no. 6, pp. 565-570, 2006.
12. S. Batra, R. Kumar, A. K. Kapoor, and G. Ray, "Alterations in antioxidant status during neonatal sepsis," Annals of Tropical Paediatrics, vol. 20, no. 1, pp. 27-33, 2000.
13. G. D. Georgeson, B. J. Szony, K. Streitman et al., "Antioxidant enzyme activities are decreased in preterm infants and in neonates born via caesarean section," European Journal ofObstetrics Gynecology and Reproductive Biology, vol. 103, no. 2,pp. 136-139, 2002.
14. I. Fogel, I. Pinchuk, M. J. Kupferminc, D. Lichtenberg, and O. Fainaru, "Oxidative stress in the fetal circulation does not depend on mode of delivery," American Journal of Obstetrics & Gynecology, vol. 193, no. 1, pp. 241-246, 2005.
15. R.-H. Fu, P.-H. Yang, M.-C. Chiang, C.-C. Chiang, Y.-H. Cho, and Y.-H. Chou, "Erythrocyte Cu/Zn superoxide dismutase activity in preterminfantswith andwithout bronchopulmonary dysplasia," Biology of the Neonate, vol. 88, no. 1, pp. 35-41, 2005.
16. D. J. Hanahan and J. E. Ekholm, "The preparation of red cell ghosts (membranes)," in Methods in Enzymology, vol. 31, pp. 168-172, 1974.
17. L. Flohé and W.A.Günzler, "Assays of glutathione peroxidase," Methods in Enzymology, vol. 105, pp. 114-121, 1984.
18. H. Aebi, "Catalase in vitro,"Methods in Enzymology, vol. 150, pp. 121-127, 1984.
19. J. D. Crapo, J. M. McCord, and I. Fridovich, "Preparation and assay of superioxide dismutases," Methods in Enzymology, vol. 53, pp. 382-393, 1978.
20. Z. Y. Jiang, J. V. Hunt, and S. P. Wolff, "Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein," Analytical Biochemistry, vol. 202, no. 2, pp. 384-389, 1992.
21. M. S. Shahab, P. Kumar, N. Sharma, A. Narang, and R. Prasad, "Evaluation of oxidant and antioxidant status in term neonates: a plausible protective role of bilirubin," Molecular and Cellular Biochemistry, vol. 317, no. 1-2, pp. 51-59, 2008.
22. T. Chard, "Fetal and maternal oxytocin in human parturition," The American Journal of Perinatology, vol. 6, no. 2, pp. 145-152, 1989.
23. A. Kiss and J. D. Mikkelsen, "Oxytocin-anatomy and functional assignments: a minireview," Endocrine Regulations, vol. 39, no. 3, pp. 97-105, 2005.
24. J. C. Mazurkiewicz, G. F. Watts, F. G. Warburton, B. M. Slavin, C. Lowy, and E. Koukkou, "Serum lipids, lipoproteins and apolipoproteins in pregnant non-diabetic patients," Journal of Clinical Pathology, vol. 47, no. 8, pp. 728-731, 1994.
25. E. J. Schaefer, D. M. Foster, L. A. Zech, F. T. Lindgren, H. B. Brewer Jr., and R. I. Levy, "The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females," Journal of Clinical Endocrinology andMetabolism, vol. 57, no. 2, pp. 262-267, 1983.
26. G. Desoye, M. O. Schweditsch, K. P. Pfeiffer, R. Zechner, and G. M. Kostner, "Correlation of hormones with lipid and lipoprotein levels during normal pregnancy and postpartum," Journal of Clinical Endocrinology andMetabolism, vol. 64, no. 4, pp. 704-712, 1987.
27. E. Herrera, "Lipid metabolism in pregnancy and its consequences in the fetus and newborn," Endocrine, vol. 19, no. 1, pp. 43-55, 2002.
28. B. Weinberger, S. Nisar, M. Anwar, B. Ostfeld, and T. Hegyi, "Lipid peroxidation in cord blood and neonatal outcome," Pediatrics International, vol. 48, no. 5, pp. 479-483, 2006.
29. B. Lachili, I. Hininger, H. Faure et al., "Increased lipid peroxidation in pregnant women after iron and vitamin C supplementation," Biological Trace Element Research, vol. 83, no. 2, pp. 103-110, 2001.
30. F. Felice, D. Lucchesi, R. di Stefano et al., "Oxidative stress in response to high glucose levels in endothelial cells and in endothelial progenitor cells. Evidence for differential glutathione peroxidase-1 expression," Microvascular Research, vol. 80, no. 3, pp. 332-338, 2010.
31. J. F. Telfer, A. J. Thomson, I. T. Cameron, I. A. Greer, and J. E. Norman, "Expression of superoxide dismutase and xanthine oxidase in myometrium, fetal membranes and placenta during normal human pregnancy and parturition," Human Reproduction, vol. 12, no. 10, pp. 2306-2312, 1997.
32. N. Sugino, M. Nakata, S. Kashida, A. Karube, S. Takiguchi, and H. Kato, "Decreased superoxide dismutase expression and increased concentrations of lipid peroxide and prostaglandin F(2α) in the decidua of failed pregnancy," Molecular Human Reproduction, vol. 6, no. 7, pp. 642-647, 2000.
33. N. M. Orsi and R. M. Tribe, "Cytokine networks and the regulation of uterine function in pregnancy and parturition," Journal of Neuroendocrinology, vol. 20,no. 4, pp. 462-469, 2008.
34. D. M. Olson, "The role of prostaglandings in the initiation of parturition," Best Practice & Research Clinical Obstetrics & Gynaecology, vol. 17, pp. 717-730, 2003.
35. I. Christiaens, D. B. Zaragoza, L. Guilbert, S. A. Robertson, B. F. Mitchell, and D.M. Olson, "Inflammatory processes in preterm and termparturition," Journal of Reproductive Immunology, vol. 79, no. 1, pp. 50-57, 2008.
36. Y. Djuardi, H. Wibowo, T. Supali et al., "Determinants of the relationship between cytokine production in pregnant women and their infants," PLoS ONE, vol. 4, no. 11, Article ID e7711, 2009.
37. R. J. Phillips, H. Al-Zamil, L. P. Hunt, M. A. Fortier, and A. López Bernal, "Genes for prostaglandin synthesis, transport and inactivation are differentially expressed in human uterine tissues, and the prostaglandin F synthase AKR1B1 is induced in myometrial cells by inflammatory cytokines,"MolecularHuman Reproduction, vol. 17, no. 1, pp. 1-13, 2011.
38. L. Gunn, P. Hardiman, S. Tharmaratnam, D. Lowe, and T. Chard, "Measurement of interleukin-1 alpha and interleukin- 6 in pregnancy-associated tissues," Reproduction, Fertility and Development, vol. 8, no. 7, pp. 1069-1073, 1996.
39. S.-L. Opsjøn, N. C. Wathen, S. Tingulstad et al., "Tumor necrosis factor, interleukin-1, and interleukin-6 in normal human pregnancy," The American Journal of Obstetrics and Gynecology, vol. 169, no. 2, pp. 397-404, 1993.
40. A. K. Yadav, H. Chaudhari, H. Warke et al., "Differential expression of collectins in human placenta and role in inflammation during spontaneous labor," PLoS ONE, vol. 9, no. 10, Article ID e108815, 2014.
41. A. Steinborn, M. Kühnert, and E. Halberstadt, "Immunmodulating cytokines induce term and preterm parturition," Journal of Perinatal Medicine, vol. 24, no. 4, pp. 381-390, 1996.
42. D. J. Dudley, D. Collmer, M. D. Mitchell, and M. S. Trautman, "Inflammatory cytokine mRNA in human gestational tissues: implications for term and preterm labor," Journal of the Society for Gynecologic Investigation, vol. 3, no. 6, pp. 328-335, 1996.
43. P. Gonzalez, F. Burgaya, L. Acarin, H. Peluffo, B. Castellano, and B. Gonzalez, "Interleukin-10 and interleukin-10 receptor- I are upregulated in glial cells after an excitotoxic injury to the postnatal rat brain," Journal of Neuropathology & Experimental Neurology, vol. 68, no. 4, pp. 391-403, 2009.
44. K. J. van Zee, T. Kohno, E. Fischer, C. S. Rock, L. L. Moldawer, and S. F. Lowry, "Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo," Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 11, pp. 4845-4849, 1992.
45. M. J. N. C. Keirse and A. C. Turnbull, "E prostaglandins in amniotic fluid during late pregnancy and labour," Journal of Obstetrics & Gynaecology of the British Commonwealth, vol. 80, no. 11, pp. 970-973, 1973.
46. M. Lappas, "Nuclear factor-κBmediates placental growth factor induced pro-labour mediators in human placenta," Molecular Human Reproduction, vol. 18, no. 7, Article ID gas007, pp. 354-361, 2012.
47. J. R. G. Challis, D. Sloboda, S. G. Matthews et al., "The fetal placental hypothalamic-pituitary-adrenal (HPA) axis, parturition and post natal health," Molecular and Cellular Endocrinology, vol. 185, no. 1-2, pp. 135-144, 2001.
48. J. R. G. Challis, D. M. Sloboda, N. Alfaidy et al., "Prostaglandins andmechanisms of pretermbirth," Reproduction, vol. 124, no. 1, pp. 1-17, 2002.